Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonvalvular atrial fibrillation and no history of stroke or transient ischemic attacks

被引：14

作者：

Aguilar, Maria I. ^{[1
]}

Hart, Robert ^{[2
]}

机构：

[1] Mayo Clin, Phoenix, AZ 85054 USA

[2] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

来源：

STROKE | 2008年 / 39卷 / 04期

关键词：

anticoagulant; antiplatelet; aspirin; atrial fibrillation; stroke; warfarin;

D O I：

10.1161/STROKEAHA.107.500363

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1399 / 1400

页数：2

共 10 条

[1] Oral anticoagulants versus antiplatelet therapy for preventing stoke in patients with non-valvular artial fibrillation and no history of stroke or transient ischemic attacks [J].

Aguilar, M., I ;

Hart, R. ;

Pearce, L. A. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03)

[2] PREVALENCE, AGE DISTRIBUTION, AND GENDER OF PATIENTS WITH ATRIAL-FIBRILLATION - ANALYSIS AND IMPLICATIONS [J].

FEINBERG, WM ;

BLACKSHEAR, JL ;

LAUPACIS, A ;

KRONMAL, R ;

HART, RG .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (05) :469-473

[3] Selecting patients with atrial fibrillation for anticoagulation - Stroke risk stratification in patients taking aspirin [J].

Gage, BF ;

van Walraven, C ;

Pearce, L ;

Hart, RG ;

Koudstaal, PJ ;

Petersen, P .

CIRCULATION, 2004, 110 (16) :2287-2292

[4] Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice? [J].

Go, AS ;

Hylek, EM ;

Chang, YC ;

Phillips, KA ;

Henault, LE ;

Capra, AM ;

Jensvold, NG ;

Selby, JV ;

Singer, DE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20) :2685-2692

[5] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].

Go, AS ;

Hylek, EM ;

Phillips, KA ;

Chang, YC ;

Henault, LE ;

Selby, JV ;

Singer, DE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375

[6] Lessons from the Stroke Prevention in Atrial Fibrillation trials [J].

Hart, RG ;

Halperin, JL ;

Pearce, LA ;

Anderson, DC ;

Kronmal, RA ;

McBride, R ;

Nasco, E ;

Sherman, DG ;

Talbert, RL ;

Marler, JR .

ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) :831-838

[7]

Hu Da-yi, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P295

[8] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial [J].

Mant, Jonathan ;

Hobbs, F. D. Richard ;

Fletcher, Kate ;

Roalfe, Andrea ;

Fitzmaurice, David ;

Lip, Gregory Y. H. ;

Murray, Ellen .

LANCET, 2007, 370 (9586) :493-503

[9] A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO) [J].

Rash, Amar ;

Downes, Tom ;

Portner, Robin ;

Yeo, Wilf W. ;

Morgan, Nicolette ;

Channer, Kevin S. .

AGE AND AGEING, 2007, 36 (02) :151-156

[10] Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation - An individual patient meta-analysis [J].

van Walraven, C ;

Hart, RG ;

Singer, DE ;

Laupacis, A ;

Connolly, S ;

Petersen, P ;

Koudstaal, PJ ;

Chang, YC ;

Hellemons, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19) :2441-2448

← 1 →